Agency
Planned Parenthood Pasadena and San Gabriel Valley INC
Planned Parenthood Pasadena and San Gabriel Valley INC was paid $5.51M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD PASADENA AND SAN GABRIEL VALLEY INC
GLENDORA, CA 91740
GLENDORA, CA 91740
33aNPI1497094114assigned 02/01/2013
33bProvider typeVoluntary or Charitable Agency
28Total paid$5.51M
24GClaims162,831
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Voluntary or Charitable Agency providers in California
Rank by total paid#5 of 35
Median peer was paid$847K
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,273 | $1.77M | |
| 2019 | 22,199 | $732K | |
| 2020 | 18,118 | $609K | |
| 2021 | 26,939 | $953K | |
| 2022 | 18,780 | $541K | |
| 2023 | 17,669 | $497K | |
| 2024incomplete | 13,853 | $412K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 9,760 | 9,515 | $1.05M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12% | 23,428 | 21,282 | $657K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 23,372 | 21,293 | $625K |
| J3490 | Unclassified drugs | 11% | 23,389 | 19,365 | $594K |
| S4993 | Contraceptive pills for birth control | 9.5% | 4,054 | 4,010 | $525K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 1,966 | 1,948 | $311K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5.3% | 4,974 | 4,927 | $293K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.3% | 1,623 | 1,620 | $292K |
| 87806 | 4.7% | 11,824 | 9,562 | $261K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.3% | 864 | 862 | $236K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 1,307 | 1,295 | $120K |
| 99201 | 1.6% | 728 | 725 | $87K |
24 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.5% | 2,936 | $85K |
| A4267 | Contraceptive supply, condom, male, each | 1.2% | 15,877 | $66K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1.2% | 95 | $65K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,794 | $36K |
| 81025 | <1% | 11,104 | $33K | |
| S5199 | Personal care item, nos, each | <1% | 3,726 | $31K |
| 99000 | <1% | 6,775 | $23K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,119 | $22K |
| 11981 | <1% | 106 | $19K | |
| S5000 | Prescription drug, generic | <1% | 2,065 | $17K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 14 | $9K |
| 83986 | <1% | 3,346 | $9K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,315 | $8K |
| 58300 | <1% | 92 | $8K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $7K |
| S5001 | Prescription drug, brand name | <1% | 1,500 | $5K |
| 87210 | <1% | 1,809 | $5K | |
| 11976 | <1% | 54 | $3K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 12 | $3K |
| 81002 | <1% | 570 | $1K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 104 | $307.77 |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 56 | $204.96 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 24 | $122.97 |
| 36415 | Collection of venous blood by venipuncture | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialESHLEMAN, BETHANY (VP OF PATIENT SERVICES)